# Advisor Review - GPT-5.2

**Role:** Academic advisor checking for fatal errors
**Model:** gpt-5.2-2025-12-11
**Paper:** paper.pdf
**Timestamp:** 2026-01-30T13:02:26.233205
**Response ID:** resp_08b4e969d8f0373800697c81378b408195ad126a81e0561ff5
**Tokens:** 15860 in / 4449 out
**Response SHA256:** 6efc5a5a94748b6b

---

No fatal errors detected under the four categories you specified.

### 1) Data–Design Alignment (Critical)
- **Treatment timing vs. data coverage:** Treatment cohorts run through **Feb 2025** (NJ coded Feb 2025). Outcome data run through **June 2025**. So **max(treatment date) ≤ max(data date)** holds.
- **Post-treatment observations:** Every treated cohort has post-treatment months through June 2025 (e.g., Jan 2025 cohort has 6 months; Feb 2025 cohort has 5 months).
- **Treatment definition consistency:** The “first full month under the law” coding for **UT (Jan 2024)** and **NJ (Feb 2025)** is stated in Table 1 notes and used consistently in the event-time definition and captions.

### 2) Regression Sanity (Critical)
Checked all reported result tables (Tables 3–5, Table 4 robustness, Appendix Table A1):
- No implausible coefficient magnitudes for the level outcome (applications).
- No SE pathologies (no SE orders of magnitude larger than coefficients; no massive/absurd values).
- No impossible values (no NaN/Inf/negative SEs; no R² reported, but also none outside [0,1]).

### 3) Completeness (Critical)
- All regression tables report **estimates + standard errors** and report **N/observations** and **# states**.
- Robustness checks described (leave-one-out range, Sun–Abraham, short pre-period, wild bootstrap) are actually reported in Table 4 / Appendix Table A1.
- Tables/figures referenced in the excerpt (Tables 1–5, Figures 1–3, Appendix A1) appear to exist in the draft as provided; no placeholders like TBD/XXX/NA in quantitative entries.

### 4) Internal Consistency (Critical)
- Core magnitudes match internally: 240 ATT corresponds to ~11.1% of the treated pre-mean (240/2168 ≈ 0.111).
- Observation counts are internally consistent (49 states × 90 months = 4,410).
- Treatment cohorts listed in Table 1 match the treated-state list used in summary stats and the design description.

ADVISOR VERDICT: PASS